Condition
Diabetic Foot Infections
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
3 of 3 completed with results
Key Signals
3 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 2 (2)
Trial Status
Completed3
Not Yet Recruiting1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06232421Phase 2Not Yet RecruitingPrimary
Clinical Study in Adult Patients With Purulent-inflammatory Processes of the Skin and Soft Tissues, Phase I-II of the Wound Process
NCT00685698Phase 2CompletedPrimary
Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections
NCT01539811Not ApplicableTerminatedPrimary
Diabetic Foot Infection Antibiotic Study
NCT02737722Phase 1CompletedPrimary
Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus
NCT00737269Completed
A Complicated Skin and Soft-tissue Infection Patient Registry
Showing all 5 trials